Ho Grace, Leung Victor Y L, Cheung Kenneth M C, Chan Danny
Department of Orthopaedics and Traumatology, University of Hong Kong, Hong Kong.
Connect Tissue Res. 2008;49(1):15-21. doi: 10.1080/03008200701818595.
Mesenchymal stem cell (MSC) implantation has been shown previously to arrest disc degeneration. This study aims to assess the effect of severity of disc degeneration on the ability of MSCs to arrest the degeneration. Disc degeneration was induced in New Zealand white rabbits at lumbar levels by annular puncture. The degeneration was allowed to progress for 1 month (early group) or 7 months (late group), followed by intradiscal injection of autologous MSCs. For disc levels that received MSCs treatment, 1 x 10(5) BrdU-labeled MSCs were injected per disc level. For the early group, MSC-injection had no significant effects on disc height or the progression of disc degeneration. For the late group, although the MSC-injected discs displayed lower disc heights than the control discs, they were significantly less degenerated together with near normal level of proteoglycan in localized areas. This is the first pilot study to demonstrate that severity of degeneration can influence the therapeutic effect of MSCs. Future studies of cell-based intervertebral disc regeneration should be carefully controlled in the context of stage of disc degeneration.
间充质干细胞(MSC)植入已被证明可阻止椎间盘退变。本研究旨在评估椎间盘退变的严重程度对MSC阻止退变能力的影响。通过环形穿刺在新西兰白兔的腰椎水平诱导椎间盘退变。退变持续进展1个月(早期组)或7个月(晚期组),随后进行椎间盘内自体MSC注射。对于接受MSC治疗的椎间盘节段,每个节段注射1×10⁵个BrdU标记的MSC。对于早期组,MSC注射对椎间盘高度或椎间盘退变进展无显著影响。对于晚期组,尽管注射MSC的椎间盘高度低于对照椎间盘,但它们的退变程度明显较轻,局部区域的蛋白聚糖水平接近正常。这是第一项初步研究,表明退变严重程度可影响MSC的治疗效果。未来基于细胞的椎间盘再生研究应在椎间盘退变阶段的背景下进行仔细控制。